Steven I. Sherman is Naguib Samaan Distinguished Professor and Chair of the Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, at The University of Texas MD Anderson Cancer Center.
He received his medical degree from The Johns Hopkins School of Medicine, in Baltimore, Maryland, where he also completed his internship and residency in internal medicine and his fellowship in endocrinology and metabolism. Dr. Sherman holds board certifications in internal medicine and endocrinology, diabetes, and metabolism.
He is the director of the National Thyroid Cancer Treatment Cooperative Study Group, member of the Thyroid Cancer Panel of the National Comprehensive Cancer Network Guidelines Program, and Chairman of the International Thyroid Oncology Group. Dr. Sherman’s current and past research has focused on the management of patients with differentiated and medullary thyroid carcinomas.
He has emphasized two broad categories of research: what are the optimal uses of therapy and diagnostic monitoring for patients with low risk differentiated thyroid carcinomas, and what novel therapies can be used for patients with advanced thyroid carcinomas that are not responsive to more typical interventions. Dr. Sherman is author or co-author on more than 100 peer reviewed publications.